APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cytochrome P450 11B2 Mitochondrial

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cytochrome P450 11B2 Mitochondrial Market Analysis and Forecast 2026-2032

Report ID 173982120219 December 2025195 pages

Choose your research edition.

Industry ResearchCytochrome P450 11B2 Mitochondrial Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cytochrome P450 11B2 Mitochondrial Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Cytochrome P450 11B2 Mitochondrial Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cytochrome P450 11B2 Mitochondrial Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cytochrome P450 11B2 Mitochondrial Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cytochrome P450 11B2 Mitochondrial market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cytochrome P450 11B2 Mitochondrial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cytochrome P450 11B2 Mitochondrial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cytochrome P450 11B2 Mitochondrial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cytochrome P450 11B2 Mitochondrial is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cytochrome P450 11B2 Mitochondrial include Novartis AG, Merck & Co Inc, Daiichi Sankyo Co Ltd, Target Medicals LLC, Boehringer Ingelheim GmbH and Angion Biomedica Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cytochrome P450 11B2 Mitochondrial, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cytochrome P450 11B2 Mitochondrial, also provides the revenue of main regions and countries. Of the upcoming market potential for Cytochrome P450 11B2 Mitochondrial, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cytochrome P450 11B2 Mitochondrial revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cytochrome P450 11B2 Mitochondrial market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cytochrome P450 11B2 Mitochondrial revenue, projected growth trends, production technology, application and end-user industry.

Cytochrome P450 11B2 Mitochondrial Segment by Company

Novartis AG

Merck & Co Inc

Daiichi Sankyo Co Ltd

Target Medicals LLC

Boehringer Ingelheim GmbH

Angion Biomedica Corp

Cytochrome P450 11B2 Mitochondrial Segment by Type

Osilodrostat Phosphate

DP-13

BI-689648

Others

Cytochrome P450 11B2 Mitochondrial Segment by Application

Myocardial Fibrosis

Kidney Fibrosis

Prostate Cancer

Hypertension

Others

Cytochrome P450 11B2 Mitochondrial Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytochrome P450 11B2 Mitochondrial market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cytochrome P450 11B2 Mitochondrial and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytochrome P450 11B2 Mitochondrial.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cytochrome P450 11B2 Mitochondrial in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cytochrome P450 11B2 Mitochondrial company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytochrome P450 11B2 Mitochondrial revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cytochrome P450 11B2 Mitochondrial Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Osilodrostat Phosphate Major Player Table 3. DP-13 Major Player Table 4. BI-689648 Major Player Table 5. Others Major Player Table 6. Global Cytochrome P450 11B2 Mitochondrial Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Myocardial Fibrosis Major Player Table 8. Kidney Fibrosis Major Player Table 9. Prostate Cancer Major Player Table 10. Hypertension Major Player Table 11. Others Major Player Table 12. Cytochrome P450 11B2 Mitochondrial Industry Trends Table 13. Cytochrome P450 11B2 Mitochondrial Industry Drivers Table 14. Cytochrome P450 11B2 Mitochondrial Industry Opportunities and Challenges Table 15. Cytochrome P450 11B2 Mitochondrial Industry Restraints Table 16. Global Cytochrome P450 11B2 Mitochondrial Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Cytochrome P450 11B2 Mitochondrial Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Cytochrome P450 11B2 Mitochondrial Market Share by Region (2021-2026) Table 19. Global Cytochrome P450 11B2 Mitochondrial Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Cytochrome P450 11B2 Mitochondrial Market Share by Region (2027-2032) Table 21. Global Cytochrome P450 11B2 Mitochondrial Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Players (2021-2026) Table 23. Global Cytochrome P450 11B2 Mitochondrial Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Cytochrome P450 11B2 Mitochondrial Key Players Headquarters & Area Served Table 25. Global Cytochrome P450 11B2 Mitochondrial Players, Product Type & Application Table 26. Global Cytochrome P450 11B2 Mitochondrial Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cytochrome P450 11B2 Mitochondrial by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Cytochrome P450 11B2 Mitochondrial Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Type (2021-2026) Table 33. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Type (2027-2032) Table 34. Global Cytochrome P450 11B2 Mitochondrial Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Application (2021-2026) Table 38. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Application (2027-2032) Table 39. Novartis AG Company Information Table 40. Novartis AG Business Overview Table 41. Novartis AG Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novartis AG Cytochrome P450 11B2 Mitochondrial Product Portfolio Table 43. Novartis AG Recent Development Table 44. Merck & Co Inc Company Information Table 45. Merck & Co Inc Business Overview Table 46. Merck & Co Inc Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Merck & Co Inc Cytochrome P450 11B2 Mitochondrial Product Portfolio Table 48. Merck & Co Inc Recent Development Table 49. Daiichi Sankyo Co Ltd Company Information Table 50. Daiichi Sankyo Co Ltd Business Overview Table 51. Daiichi Sankyo Co Ltd Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Daiichi Sankyo Co Ltd Cytochrome P450 11B2 Mitochondrial Product Portfolio Table 53. Daiichi Sankyo Co Ltd Recent Development Table 54. Target Medicals LLC Company Information Table 55. Target Medicals LLC Business Overview Table 56. Target Medicals LLC Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Target Medicals LLC Cytochrome P450 11B2 Mitochondrial Product Portfolio Table 58. Target Medicals LLC Recent Development Table 59. Boehringer Ingelheim GmbH Company Information Table 60. Boehringer Ingelheim GmbH Business Overview Table 61. Boehringer Ingelheim GmbH Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Boehringer Ingelheim GmbH Cytochrome P450 11B2 Mitochondrial Product Portfolio Table 63. Boehringer Ingelheim GmbH Recent Development Table 64. Angion Biomedica Corp Company Information Table 65. Angion Biomedica Corp Business Overview Table 66. Angion Biomedica Corp Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Angion Biomedica Corp Cytochrome P450 11B2 Mitochondrial Product Portfolio Table 68. Angion Biomedica Corp Recent Development Table 69. North America Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Cytochrome P450 11B2 Mitochondrial Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country (US$ Million) & (2027-2032) Table 83. China Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026) & (US$ Million) Table 84. China Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032) & (US$ Million) Table 85. China Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026) & (US$ Million) Table 86. China Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Cytochrome P450 11B2 Mitochondrial Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Cytochrome P450 11B2 Mitochondrial Image Figure 2. Global Cytochrome P450 11B2 Mitochondrial Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cytochrome P450 11B2 Mitochondrial Market Size Share 2021 VS 2025 VS 2032 Figure 4. Osilodrostat Phosphate Image Figure 5. DP-13 Image Figure 6. BI-689648 Image Figure 7. Others Image Figure 8. Global Cytochrome P450 11B2 Mitochondrial Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Cytochrome P450 11B2 Mitochondrial Market Size Share 2021 VS 2025 VS 2032 Figure 10. Myocardial Fibrosis Image Figure 11. Kidney Fibrosis Image Figure 12. Prostate Cancer Image Figure 13. Hypertension Image Figure 14. Others Image Figure 15. Global Cytochrome P450 11B2 Mitochondrial Market Size (US$ Million) & (2021-2032) Figure 16. Global Cytochrome P450 11B2 Mitochondrial Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Cytochrome P450 11B2 Mitochondrial Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Cytochrome P450 11B2 Mitochondrial Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Type (2021-2032) Figure 23. Global Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Application (2021-2032) Figure 26. North America Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032) Figure 28. North America Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032) Figure 29. North America Cytochrome P450 11B2 Mitochondrial Revenue Share by Country (2021-2032) Figure 30. United States Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032) Figure 35. Europe Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032) Figure 36. Europe Cytochrome P450 11B2 Mitochondrial Revenue Share by Country (2021-2032) Figure 37. Germany Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032) Figure 47. China Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032) Figure 48. Asia Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032) Figure 50. Asia Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032) Figure 51. Asia Cytochrome P450 11B2 Mitochondrial Revenue Share by Region (2021-2032) Figure 52. Japan Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032) Figure 60. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032) Figure 61. SAMEA Cytochrome P450 11B2 Mitochondrial Revenue Share by Country (2021-2032) Figure 62. Brazil Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Cytochrome P450 11B2 Mitochondrial Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Osilodrostat Phosphate
  • DP-13
  • BI-689648
  • Others
Applications
  • Myocardial Fibrosis
  • Kidney Fibrosis
  • Prostate Cancer
  • Hypertension
  • Others
Companies covered
  • Novartis AG
  • Merck & Co Inc
  • Daiichi Sankyo Co Ltd
  • Target Medicals LLC
  • Boehringer Ingelheim GmbH
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cytochrome P450 11B2 Mitochondrial Market by Type
  3. 1.2.1 Global Cytochrome P450 11B2 Mitochondrial Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Osilodrostat Phosphate
  5. 1.2.3 DP-13
  6. 1.2.4 BI-689648
  7. 1.2.5 Others
  8. 1.3 Cytochrome P450 11B2 Mitochondrial Market by Application
  9. 1.3.1 Global Cytochrome P450 11B2 Mitochondrial Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Myocardial Fibrosis
  11. 1.3.3 Kidney Fibrosis
  12. 1.3.4 Prostate Cancer
  13. 1.3.5 Hypertension
  14. 1.3.6 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Cytochrome P450 11B2 Mitochondrial Market Dynamics
  1. 2.1 Cytochrome P450 11B2 Mitochondrial Industry Trends
  2. 2.2 Cytochrome P450 11B2 Mitochondrial Industry Drivers
  3. 2.3 Cytochrome P450 11B2 Mitochondrial Industry Opportunities and Challenges
  4. 2.4 Cytochrome P450 11B2 Mitochondrial Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cytochrome P450 11B2 Mitochondrial Market Perspective (2021-2032)
  2. 3.2 Global Cytochrome P450 11B2 Mitochondrial Growth Trends by Region
  3. 3.2.1 Global Cytochrome P450 11B2 Mitochondrial Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cytochrome P450 11B2 Mitochondrial Market Size by Region (2021-2026)
  5. 3.2.3 Global Cytochrome P450 11B2 Mitochondrial Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cytochrome P450 11B2 Mitochondrial Revenue by Players
  2. 4.1.1 Global Cytochrome P450 11B2 Mitochondrial Revenue by Players (2021-2026)
  3. 4.1.2 Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cytochrome P450 11B2 Mitochondrial Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cytochrome P450 11B2 Mitochondrial Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cytochrome P450 11B2 Mitochondrial Key Players Headquarters & Area Served
  7. 4.4 Global Cytochrome P450 11B2 Mitochondrial Players, Product Type & Application
  8. 4.5 Global Cytochrome P450 11B2 Mitochondrial Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cytochrome P450 11B2 Mitochondrial Market CR5 and HHI
  11. 4.6.3 2025 Cytochrome P450 11B2 Mitochondrial Tier 1, Tier 2, and Tier 3
5 Cytochrome P450 11B2 Mitochondrial Market Size by Type
  1. 5.1 Global Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2032)
  3. 5.3 Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Type (2021-2032)
6 Cytochrome P450 11B2 Mitochondrial Market Size by Application
  1. 6.1 Global Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2032)
  3. 6.3 Global Cytochrome P450 11B2 Mitochondrial Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Cytochrome P450 11B2 Mitochondrial Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Merck & Co Inc
  8. 7.2.1 Merck & Co Inc Company Information
  9. 7.2.2 Merck & Co Inc Business Overview
  10. 7.2.3 Merck & Co Inc Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co Inc Cytochrome P450 11B2 Mitochondrial Product Portfolio
  12. 7.2.5 Merck & Co Inc Recent Developments
  13. 7.3 Daiichi Sankyo Co Ltd
  14. 7.3.1 Daiichi Sankyo Co Ltd Company Information
  15. 7.3.2 Daiichi Sankyo Co Ltd Business Overview
  16. 7.3.3 Daiichi Sankyo Co Ltd Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Daiichi Sankyo Co Ltd Cytochrome P450 11B2 Mitochondrial Product Portfolio
  18. 7.3.5 Daiichi Sankyo Co Ltd Recent Developments
  19. 7.4 Target Medicals LLC
  20. 7.4.1 Target Medicals LLC Company Information
  21. 7.4.2 Target Medicals LLC Business Overview
  22. 7.4.3 Target Medicals LLC Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Target Medicals LLC Cytochrome P450 11B2 Mitochondrial Product Portfolio
  24. 7.4.5 Target Medicals LLC Recent Developments
  25. 7.5 Boehringer Ingelheim GmbH
  26. 7.5.1 Boehringer Ingelheim GmbH Company Information
  27. 7.5.2 Boehringer Ingelheim GmbH Business Overview
  28. 7.5.3 Boehringer Ingelheim GmbH Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Boehringer Ingelheim GmbH Cytochrome P450 11B2 Mitochondrial Product Portfolio
  30. 7.5.5 Boehringer Ingelheim GmbH Recent Developments
  31. 7.6 Angion Biomedica Corp
  32. 7.6.1 Angion Biomedica Corp Company Information
  33. 7.6.2 Angion Biomedica Corp Business Overview
  34. 7.6.3 Angion Biomedica Corp Cytochrome P450 11B2 Mitochondrial Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Angion Biomedica Corp Cytochrome P450 11B2 Mitochondrial Product Portfolio
  36. 7.6.5 Angion Biomedica Corp Recent Developments
8 North America
  1. 8.1 North America Cytochrome P450 11B2 Mitochondrial Revenue (2021-2032)
  2. 8.2 North America Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2032)
  3. 8.2.1 North America Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026)
  4. 8.2.2 North America Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032)
  5. 8.3 North America Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032)
  6. 8.4 North America Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2032)
  7. 8.4.1 North America Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026)
  8. 8.4.2 North America Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032)
  9. 8.5 North America Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032)
  10. 8.6 North America Cytochrome P450 11B2 Mitochondrial Revenue by Country
  11. 8.6.1 North America Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026)
  13. 8.6.3 North America Cytochrome P450 11B2 Mitochondrial Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Cytochrome P450 11B2 Mitochondrial Revenue (2021-2032)
  2. 9.2 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032)
  5. 9.3 Europe Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032)
  9. 9.5 Europe Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country
  11. 9.6.1 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cytochrome P450 11B2 Mitochondrial Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Cytochrome P450 11B2 Mitochondrial Revenue (2021-2032)
  2. 10.2 China Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2032)
  3. 10.2.1 China Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026)
  4. 10.2.2 China Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032)
  5. 10.3 China Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032)
  6. 10.4 China Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2032)
  7. 10.4.1 China Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026)
  8. 10.4.2 China Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032)
  9. 10.5 China Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cytochrome P450 11B2 Mitochondrial Revenue (2021-2032)
  2. 11.2 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032)
  5. 11.3 Asia Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032)
  9. 11.5 Asia Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Country
  11. 11.6.1 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cytochrome P450 11B2 Mitochondrial Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue (2021-2032)
  2. 12.2 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country
  11. 12.6.1 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cytochrome P450 11B2 Mitochondrial Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst